Skip to main content

Early Detection, Diagnosis, and Staging of Rhabdomyosarcoma

Learn about the signs and symptoms of rhabdomyosarcoma, the tests that may be done for it, and the outlook for those with a diagnosis.

Can rhabdomyosarcoma be found early?

Rhabdomyosarcoma (RMS) is not common, and at this time there are no recommended screening tests for these cancers. Screening is testing for a disease such as cancer in people who do not have any symptoms.

Families known to carry inherited conditions that raise the risk of RMS (listed in Rhabdomyosarcoma Causes, Risk Factors, and Prevention) or that have several family members with cancer (particularly childhood cancers) should talk with their doctors about the possible need for more frequent checkups. It is not common for RMS to run in families, but close attention to possible early signs of cancer might help find it early.

What are the signs and symptoms of rhabdomyosarcoma?

RMS can lead to symptoms that cause a child to go to the doctor. Symptoms from RMS depend on the location of the tumor. Symptoms can include:

  • A lump in the neck, arms or legs
  • Changes in vision
  • Bleeding, especially vaginal bleeding or blood in the urine if a tumor is located near the bladder or reproductive organs
  • Belly pain or swelling
  • Sinus congestion or headaches

Most symptoms that might point to RMS, such as pain, swelling and lumps, can also have other causes. Most of these symptoms are not from cancer. But if they persist or do not go away after a week or so, it is important to have them checked by a doctor.

How is rhabdomyosarcoma diagnosed?

Diagnosing RMS often involves imaging tests, blood work and a biopsy of the tumor. If RMS is found, more detailed tests will be done on the tumor sample, and a bone marrow biopsy will be done to learn more about the RMS and if it has spread to decide how best to treat it.

Some of these tests are also used to track how well treatment is working.

Stages, risk groups, and outlook for childhood rhabdomyosarcoma

After a rhabdomyosarcoma diagnosis, many people want to understand what to expect. Doctors use information about a tumor’s location, stage (extent), whether or not it can be removed with surgery and gene changes to assign a risk group. Risk groups refer to how likely it is that the cancer might recur or come back after treatment. They are used to decide what treatment is best for each specific case.

Risk groups are important in estimating a child’s outlook (prognosis) for survival.

Survival rates are a way to measure how many people survive a certain type of cancer over time. Survival rates are often reported as 5-year survival rates, which refer to the percentage of children who live at least 5 years after their cancer diagnosis. Of course, many children live much longer than 5 years (and many are cured). Some people find this information helpful, while others prefer to focus more on treatment plans and next steps.

Questions to ask if rhabdomyosarcoma has just been diagnosed

  • What type of RMS does my child have?
  • Where exactly is the tumor?
  • How much experience do you have treating this type of cancer?
  • Will we need to see other doctors?
  • Who else will be on the treatment team, and what do they do?
  • What tests do we need before we can decide on treatment?
  • Who will do these tests?
  • Who can explain them to us?
  • How and when will we get the results?
  • Who will explain the results to us?
  • What will happen during the biopsy? How much experience do you have doing biopsies like this?
  • How long will it take to get the results from the biopsy?
  • Which risk group does the cancer fall into, and what does that mean?
  • What are our treatment options?
  • Are there any clinical trials we might want to consider?
  • What do you recommend and why?
  • What is the goal of treatment?
  • Should we get a second opinion? How do we do that? Can you recommend a doctor or cancer center?

side by side logos for American Cancer Society and American Society of Clinical Oncology

Developed by the American Cancer Society medical and editorial content team with medical review and contribution by the American Society of Clinical Oncology (ASCO).

Linardic CM, Wexler, LH. Chapter 25: Rhabdomyosarcoma. In: Blaney SM, Adamson PC, Helman LJ, eds. Pizzo and Poplack’s Principles and Practice of Pediatric Oncology. 8th ed. Philadelphia Pa: Lippincott Williams & Wilkins; 2021.

Okcu MF, Hicks J. Rhabdomyosarcoma in childhood and adolescence: Clinical presentation, diagnostic evaluation, and staging. UpToDate. 2025. Accessed at www.uptodate.com/contents/rhabdomyosarcoma-in-childhood-and-adolescence-clinical-presentation-diagnostic-evaluation-and-staging on April 3, 2025.

Last Revised: June 2, 2025

American Cancer Society Emails

Sign up to stay up-to-date with news, valuable information, and ways to get involved with the American Cancer Society.